 | • レポートコード：QYR2104Z2458 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、フラグメント創薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（フラグメントスクリーニング、フラグメントオプティマイゼーション）、用途別市場規模（学術研究機関、バイオ医薬品企業、委託研究機関（CRO））、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・フラグメント創薬の市場動向 ・企業の競争状況、市場シェア ・フラグメント創薬の種類別市場規模（フラグメントスクリーニング、フラグメントオプティマイゼーション） ・フラグメント創薬の用途別市場規模（学術研究機関、バイオ医薬品企業、委託研究機関（CRO）） ・フラグメント創薬の北米市場規模2016-2027（アメリカ、カナダ） ・フラグメント創薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・フラグメント創薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・フラグメント創薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・フラグメント創薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Astex Pharmaceuticals、Alveus Pharmaceuticals、Beactica、Charles River Laboratories、Crown Bioscience、Emerald BioStructures、Evotec、Kinetic Discovery、Proteros Fragments、Sprint Bioscience、Structure Based Design、Sygnature Discovery） ・結論 |
The introduction of new techniques into the existing fragment-based drug discovery practices have created significant reductions in time and cost, driving the demand for such practices.
Market Analysis and Insights: Global Fragment-based Drug Discovery Market
The global Fragment-based Drug Discovery market size is projected to reach US$ 501.2 million by 2026, from US$ 320.5 million in 2019, at a CAGR of 6.5% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Fragment-based Drug Discovery market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Fragment-based Drug Discovery market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Fragment-based Drug Discovery market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Fragment-based Drug Discovery market.
Global Fragment-based Drug Discovery Scope and Market Size
Fragment-based Drug Discovery market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Fragment-based Drug Discovery market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Fragment Screening
Fragment Optimization
Segment by Application
Academic and Research Institutions
Biopharmaceutical Companies
Contract Research Organizations (CROs)
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Astex Pharmaceuticals
Alveus Pharmaceuticals
Beactica
Charles River Laboratories
Crown Bioscience
Emerald BioStructures
Evotec
Kinetic Discovery
Proteros Fragments
Charles River Laboratories
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Fragment-based Drug Discovery Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Fragment Screening
1.2.3 Fragment Optimization
1.3 Market by Application
1.3.1 Global Fragment-based Drug Discovery Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Academic and Research Institutions
1.3.3 Biopharmaceutical Companies
1.3.4 Contract Research Organizations (CROs)
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Fragment-based Drug Discovery Market Perspective (2016-2027)
2.2 Fragment-based Drug Discovery Growth Trends by Regions
2.2.1 Fragment-based Drug Discovery Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Fragment-based Drug Discovery Historic Market Share by Regions (2016-2021)
2.2.3 Fragment-based Drug Discovery Forecasted Market Size by Regions (2022-2027)
2.3 Fragment-based Drug Discovery Industry Dynamic
2.3.1 Fragment-based Drug Discovery Market Trends
2.3.2 Fragment-based Drug Discovery Market Drivers
2.3.3 Fragment-based Drug Discovery Market Challenges
2.3.4 Fragment-based Drug Discovery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Fragment-based Drug Discovery Players by Revenue
3.1.1 Global Top Fragment-based Drug Discovery Players by Revenue (2016-2021)
3.1.2 Global Fragment-based Drug Discovery Revenue Market Share by Players (2016-2021)
3.2 Global Fragment-based Drug Discovery Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Fragment-based Drug Discovery Revenue
3.4 Global Fragment-based Drug Discovery Market Concentration Ratio
3.4.1 Global Fragment-based Drug Discovery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Fragment-based Drug Discovery Revenue in 2020
3.5 Fragment-based Drug Discovery Key Players Head office and Area Served
3.6 Key Players Fragment-based Drug Discovery Product Solution and Service
3.7 Date of Enter into Fragment-based Drug Discovery Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Fragment-based Drug Discovery Breakdown Data by Type
4.1 Global Fragment-based Drug Discovery Historic Market Size by Type (2016-2021)
4.2 Global Fragment-based Drug Discovery Forecasted Market Size by Type (2022-2027)
5 Fragment-based Drug Discovery Breakdown Data by Application
5.1 Global Fragment-based Drug Discovery Historic Market Size by Application (2016-2021)
5.2 Global Fragment-based Drug Discovery Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Fragment-based Drug Discovery Market Size (2016-2027)
6.2 North America Fragment-based Drug Discovery Market Size by Type
6.2.1 North America Fragment-based Drug Discovery Market Size by Type (2016-2021)
6.2.2 North America Fragment-based Drug Discovery Market Size by Type (2022-2027)
6.2.3 North America Fragment-based Drug Discovery Market Size by Type (2016-2027)
6.3 North America Fragment-based Drug Discovery Market Size by Application
6.3.1 North America Fragment-based Drug Discovery Market Size by Application (2016-2021)
6.3.2 North America Fragment-based Drug Discovery Market Size by Application (2022-2027)
6.3.3 North America Fragment-based Drug Discovery Market Size by Application (2016-2027)
6.4 North America Fragment-based Drug Discovery Market Size by Country
6.4.1 North America Fragment-based Drug Discovery Market Size by Country (2016-2021)
6.4.2 North America Fragment-based Drug Discovery Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Fragment-based Drug Discovery Market Size (2016-2027)
7.2 Europe Fragment-based Drug Discovery Market Size by Type
7.2.1 Europe Fragment-based Drug Discovery Market Size by Type (2016-2021)
7.2.2 Europe Fragment-based Drug Discovery Market Size by Type (2022-2027)
7.2.3 Europe Fragment-based Drug Discovery Market Size by Type (2016-2027)
7.3 Europe Fragment-based Drug Discovery Market Size by Application
7.3.1 Europe Fragment-based Drug Discovery Market Size by Application (2016-2021)
7.3.2 Europe Fragment-based Drug Discovery Market Size by Application (2022-2027)
7.3.3 Europe Fragment-based Drug Discovery Market Size by Application (2016-2027)
7.4 Europe Fragment-based Drug Discovery Market Size by Country
7.4.1 Europe Fragment-based Drug Discovery Market Size by Country (2016-2021)
7.4.2 Europe Fragment-based Drug Discovery Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Fragment-based Drug Discovery Market Size (2016-2027)
8.2 Asia-Pacific Fragment-based Drug Discovery Market Size by Type
8.2.1 Asia-Pacific Fragment-based Drug Discovery Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Fragment-based Drug Discovery Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Fragment-based Drug Discovery Market Size by Type (2016-2027)
8.3 Asia-Pacific Fragment-based Drug Discovery Market Size by Application
8.3.1 Asia-Pacific Fragment-based Drug Discovery Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Fragment-based Drug Discovery Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Fragment-based Drug Discovery Market Size by Application (2016-2027)
8.4 Asia-Pacific Fragment-based Drug Discovery Market Size by Region
8.4.1 Asia-Pacific Fragment-based Drug Discovery Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Fragment-based Drug Discovery Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Fragment-based Drug Discovery Market Size (2016-2027)
9.2 Latin America Fragment-based Drug Discovery Market Size by Type
9.2.1 Latin America Fragment-based Drug Discovery Market Size by Type (2016-2021)
9.2.2 Latin America Fragment-based Drug Discovery Market Size by Type (2022-2027)
9.2.3 Latin America Fragment-based Drug Discovery Market Size by Type (2016-2027)
9.3 Latin America Fragment-based Drug Discovery Market Size by Application
9.3.1 Latin America Fragment-based Drug Discovery Market Size by Application (2016-2021)
9.3.2 Latin America Fragment-based Drug Discovery Market Size by Application (2022-2027)
9.3.3 Latin America Fragment-based Drug Discovery Market Size by Application (2016-2027)
9.4 Latin America Fragment-based Drug Discovery Market Size by Country
9.4.1 Latin America Fragment-based Drug Discovery Market Size by Country (2016-2021)
9.4.2 Latin America Fragment-based Drug Discovery Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Fragment-based Drug Discovery Market Size (2016-2027)
10.2 Middle East & Africa Fragment-based Drug Discovery Market Size by Type
10.2.1 Middle East & Africa Fragment-based Drug Discovery Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Fragment-based Drug Discovery Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Fragment-based Drug Discovery Market Size by Type (2016-2027)
10.3 Middle East & Africa Fragment-based Drug Discovery Market Size by Application
10.3.1 Middle East & Africa Fragment-based Drug Discovery Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Fragment-based Drug Discovery Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Fragment-based Drug Discovery Market Size by Application (2016-2027)
10.4 Middle East & Africa Fragment-based Drug Discovery Market Size by Country
10.4.1 Middle East & Africa Fragment-based Drug Discovery Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Fragment-based Drug Discovery Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Astex Pharmaceuticals
11.1.1 Astex Pharmaceuticals Company Details
11.1.2 Astex Pharmaceuticals Business Overview
11.1.3 Astex Pharmaceuticals Fragment-based Drug Discovery Introduction
11.1.4 Astex Pharmaceuticals Revenue in Fragment-based Drug Discovery Business (2016-2021)
11.1.5 Astex Pharmaceuticals Recent Development
11.2 Alveus Pharmaceuticals
11.2.1 Alveus Pharmaceuticals Company Details
11.2.2 Alveus Pharmaceuticals Business Overview
11.2.3 Alveus Pharmaceuticals Fragment-based Drug Discovery Introduction
11.2.4 Alveus Pharmaceuticals Revenue in Fragment-based Drug Discovery Business (2016-2021)
11.2.5 Alveus Pharmaceuticals Recent Development
11.3 Beactica
11.3.1 Beactica Company Details
11.3.2 Beactica Business Overview
11.3.3 Beactica Fragment-based Drug Discovery Introduction
11.3.4 Beactica Revenue in Fragment-based Drug Discovery Business (2016-2021)
11.3.5 Beactica Recent Development
11.4 Charles River Laboratories
11.4.1 Charles River Laboratories Company Details
11.4.2 Charles River Laboratories Business Overview
11.4.3 Charles River Laboratories Fragment-based Drug Discovery Introduction
11.4.4 Charles River Laboratories Revenue in Fragment-based Drug Discovery Business (2016-2021)
11.4.5 Charles River Laboratories Recent Development
11.5 Crown Bioscience
11.5.1 Crown Bioscience Company Details
11.5.2 Crown Bioscience Business Overview
11.5.3 Crown Bioscience Fragment-based Drug Discovery Introduction
11.5.4 Crown Bioscience Revenue in Fragment-based Drug Discovery Business (2016-2021)
11.5.5 Crown Bioscience Recent Development
11.6 Emerald BioStructures
11.6.1 Emerald BioStructures Company Details
11.6.2 Emerald BioStructures Business Overview
11.6.3 Emerald BioStructures Fragment-based Drug Discovery Introduction
11.6.4 Emerald BioStructures Revenue in Fragment-based Drug Discovery Business (2016-2021)
11.6.5 Emerald BioStructures Recent Development
11.7 Evotec
11.7.1 Evotec Company Details
11.7.2 Evotec Business Overview
11.7.3 Evotec Fragment-based Drug Discovery Introduction
11.7.4 Evotec Revenue in Fragment-based Drug Discovery Business (2016-2021)
11.7.5 Evotec Recent Development
11.8 Kinetic Discovery
11.8.1 Kinetic Discovery Company Details
11.8.2 Kinetic Discovery Business Overview
11.8.3 Kinetic Discovery Fragment-based Drug Discovery Introduction
11.8.4 Kinetic Discovery Revenue in Fragment-based Drug Discovery Business (2016-2021)
11.8.5 Kinetic Discovery Recent Development
11.9 Proteros Fragments
11.9.1 Proteros Fragments Company Details
11.9.2 Proteros Fragments Business Overview
11.9.3 Proteros Fragments Fragment-based Drug Discovery Introduction
11.9.4 Proteros Fragments Revenue in Fragment-based Drug Discovery Business (2016-2021)
11.9.5 Proteros Fragments Recent Development
11.10 Sprint Bioscience
11.10.1 Sprint Bioscience Company Details
11.10.2 Sprint Bioscience Business Overview
11.10.3 Sprint Bioscience Fragment-based Drug Discovery Introduction
11.10.4 Sprint Bioscience Revenue in Fragment-based Drug Discovery Business (2016-2021)
11.10.5 Sprint Bioscience Recent Development
11.11 Structure Based Design
11.11.1 Structure Based Design Company Details
11.11.2 Structure Based Design Business Overview
11.11.3 Structure Based Design Fragment-based Drug Discovery Introduction
11.11.4 Structure Based Design Revenue in Fragment-based Drug Discovery Business (2016-2021)
11.11.5 Structure Based Design Recent Development
11.12 Sygnature Discovery
11.12.1 Sygnature Discovery Company Details
11.12.2 Sygnature Discovery Business Overview
11.12.3 Sygnature Discovery Fragment-based Drug Discovery Introduction
11.12.4 Sygnature Discovery Revenue in Fragment-based Drug Discovery Business (2016-2021)
11.12.5 Sygnature Discovery Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Fragment-based Drug Discovery Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Fragment Screening
Table 3. Key Players of Fragment Optimization
Table 4. Global Fragment-based Drug Discovery Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Fragment-based Drug Discovery Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Fragment-based Drug Discovery Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Fragment-based Drug Discovery Market Share by Regions (2016-2021)
Table 8. Global Fragment-based Drug Discovery Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Fragment-based Drug Discovery Market Share by Regions (2022-2027)
Table 10. Fragment-based Drug Discovery Market Trends
Table 11. Fragment-based Drug Discovery Market Drivers
Table 12. Fragment-based Drug Discovery Market Challenges
Table 13. Fragment-based Drug Discovery Market Restraints
Table 14. Global Fragment-based Drug Discovery Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Fragment-based Drug Discovery Market Share by Players (2016-2021)
Table 16. Global Top Fragment-based Drug Discovery Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Fragment-based Drug Discovery as of 2020)
Table 17. Ranking of Global Top Fragment-based Drug Discovery Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Fragment-based Drug Discovery Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Fragment-based Drug Discovery Product Solution and Service
Table 21. Date of Enter into Fragment-based Drug Discovery Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Fragment-based Drug Discovery Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Fragment-based Drug Discovery Revenue Market Share by Type (2016-2021)
Table 25. Global Fragment-based Drug Discovery Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Fragment-based Drug Discovery Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Fragment-based Drug Discovery Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Fragment-based Drug Discovery Revenue Market Share by Application (2016-2021)
Table 29. Global Fragment-based Drug Discovery Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Fragment-based Drug Discovery Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Fragment-based Drug Discovery Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Fragment-based Drug Discovery Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Fragment-based Drug Discovery Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Fragment-based Drug Discovery Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Fragment-based Drug Discovery Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Fragment-based Drug Discovery Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Fragment-based Drug Discovery Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Fragment-based Drug Discovery Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Fragment-based Drug Discovery Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Fragment-based Drug Discovery Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Fragment-based Drug Discovery Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Fragment-based Drug Discovery Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Fragment-based Drug Discovery Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Fragment-based Drug Discovery Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Fragment-based Drug Discovery Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Fragment-based Drug Discovery Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Fragment-based Drug Discovery Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Fragment-based Drug Discovery Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Fragment-based Drug Discovery Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Fragment-based Drug Discovery Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Fragment-based Drug Discovery Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Fragment-based Drug Discovery Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Fragment-based Drug Discovery Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Fragment-based Drug Discovery Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Fragment-based Drug Discovery Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Fragment-based Drug Discovery Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Fragment-based Drug Discovery Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Fragment-based Drug Discovery Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Fragment-based Drug Discovery Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Fragment-based Drug Discovery Market Size by Country (2022-2027) & (US$ Million)
Table 61. Astex Pharmaceuticals Company Details
Table 62. Astex Pharmaceuticals Business Overview
Table 63. Astex Pharmaceuticals Fragment-based Drug Discovery Product
Table 64. Astex Pharmaceuticals Revenue in Fragment-based Drug Discovery Business (2016-2021) & (US$ Million)
Table 65. Astex Pharmaceuticals Recent Development
Table 66. Alveus Pharmaceuticals Company Details
Table 67. Alveus Pharmaceuticals Business Overview
Table 68. Alveus Pharmaceuticals Fragment-based Drug Discovery Product
Table 69. Alveus Pharmaceuticals Revenue in Fragment-based Drug Discovery Business (2016-2021) & (US$ Million)
Table 70. Alveus Pharmaceuticals Recent Development
Table 71. Beactica Company Details
Table 72. Beactica Business Overview
Table 73. Beactica Fragment-based Drug Discovery Product
Table 74. Beactica Revenue in Fragment-based Drug Discovery Business (2016-2021) & (US$ Million)
Table 75. Beactica Recent Development
Table 76. Charles River Laboratories Company Details
Table 77. Charles River Laboratories Business Overview
Table 78. Charles River Laboratories Fragment-based Drug Discovery Product
Table 79. Charles River Laboratories Revenue in Fragment-based Drug Discovery Business (2016-2021) & (US$ Million)
Table 80. Charles River Laboratories Recent Development
Table 81. Crown Bioscience Company Details
Table 82. Crown Bioscience Business Overview
Table 83. Crown Bioscience Fragment-based Drug Discovery Product
Table 84. Crown Bioscience Revenue in Fragment-based Drug Discovery Business (2016-2021) & (US$ Million)
Table 85. Crown Bioscience Recent Development
Table 86. Emerald BioStructures Company Details
Table 87. Emerald BioStructures Business Overview
Table 88. Emerald BioStructures Fragment-based Drug Discovery Product
Table 89. Emerald BioStructures Revenue in Fragment-based Drug Discovery Business (2016-2021) & (US$ Million)
Table 90. Emerald BioStructures Recent Development
Table 91. Evotec Company Details
Table 92. Evotec Business Overview
Table 93. Evotec Fragment-based Drug Discovery Product
Table 94. Evotec Revenue in Fragment-based Drug Discovery Business (2016-2021) & (US$ Million)
Table 95. Evotec Recent Development
Table 96. Kinetic Discovery Company Details
Table 97. Kinetic Discovery Business Overview
Table 98. Kinetic Discovery Revenue in Fragment-based Drug Discovery Business (2016-2021) & (US$ Million)
Table 99. Kinetic Discovery Recent Development
Table 100. Proteros Fragments Company Details
Table 101. Proteros Fragments Business Overview
Table 102. Proteros Fragments Fragment-based Drug Discovery Product
Table 103. Proteros Fragments Revenue in Fragment-based Drug Discovery Business (2016-2021) & (US$ Million)
Table 104. Proteros Fragments Recent Development
Table 105. Sprint Bioscience Company Details
Table 106. Sprint Bioscience Business Overview
Table 107. Sprint Bioscience Fragment-based Drug Discovery Product
Table 108. Sprint Bioscience Revenue in Fragment-based Drug Discovery Business (2016-2021) & (US$ Million)
Table 109. Sprint Bioscience Recent Development
Table 110. Structure Based Design Company Details
Table 111. Structure Based Design Business Overview
Table 112. Structure Based Design Fragment-based Drug Discovery Product
Table 113. Structure Based Design Revenue in Fragment-based Drug Discovery Business (2016-2021) & (US$ Million)
Table 114. Structure Based Design Recent Development
Table 115. Sygnature Discovery Company Details
Table 116. Sygnature Discovery Business Overview
Table 117. Sygnature Discovery Fragment-based Drug Discovery Product
Table 118. Sygnature Discovery Revenue in Fragment-based Drug Discovery Business (2016-2021) & (US$ Million)
Table 119. Sygnature Discovery Recent Development
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Fragment-based Drug Discovery Market Share by Type: 2020 VS 2027
Figure 2. Fragment Screening Features
Figure 3. Fragment Optimization Features
Figure 4. Global Fragment-based Drug Discovery Market Share by Application: 2020 VS 2027
Figure 5. Academic and Research Institutions Case Studies
Figure 6. Biopharmaceutical Companies Case Studies
Figure 7. Contract Research Organizations (CROs) Case Studies
Figure 8. Fragment-based Drug Discovery Report Years Considered
Figure 9. Global Fragment-based Drug Discovery Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Fragment-based Drug Discovery Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Fragment-based Drug Discovery Market Share by Regions: 2020 VS 2027
Figure 12. Global Fragment-based Drug Discovery Market Share by Regions (2022-2027)
Figure 13. Global Fragment-based Drug Discovery Market Share by Players in 2020
Figure 14. Global Top Fragment-based Drug Discovery Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Fragment-based Drug Discovery as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Fragment-based Drug Discovery Revenue in 2020
Figure 16. Global Fragment-based Drug Discovery Revenue Market Share by Type (2016-2021)
Figure 17. Global Fragment-based Drug Discovery Revenue Market Share by Type (2022-2027)
Figure 18. North America Fragment-based Drug Discovery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Fragment-based Drug Discovery Market Share by Type (2016-2027)
Figure 20. North America Fragment-based Drug Discovery Market Share by Application (2016-2027)
Figure 21. North America Fragment-based Drug Discovery Market Share by Country (2016-2027)
Figure 22. United States Fragment-based Drug Discovery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Fragment-based Drug Discovery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Fragment-based Drug Discovery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Fragment-based Drug Discovery Market Share by Type (2016-2027)
Figure 26. Europe Fragment-based Drug Discovery Market Share by Application (2016-2027)
Figure 27. Europe Fragment-based Drug Discovery Market Share by Country (2016-2027)
Figure 28. Germany Fragment-based Drug Discovery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Fragment-based Drug Discovery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Fragment-based Drug Discovery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Fragment-based Drug Discovery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Fragment-based Drug Discovery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Fragment-based Drug Discovery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Fragment-based Drug Discovery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Fragment-based Drug Discovery Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Fragment-based Drug Discovery Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Fragment-based Drug Discovery Market Share by Region (2016-2027)
Figure 38. China Fragment-based Drug Discovery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Fragment-based Drug Discovery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Fragment-based Drug Discovery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Fragment-based Drug Discovery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Fragment-based Drug Discovery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Fragment-based Drug Discovery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Fragment-based Drug Discovery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Fragment-based Drug Discovery Market Share by Type (2016-2027)
Figure 46. Latin America Fragment-based Drug Discovery Market Share by Application (2016-2027)
Figure 47. Latin America Fragment-based Drug Discovery Market Share by Country (2016-2027)
Figure 48. Mexico Fragment-based Drug Discovery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Fragment-based Drug Discovery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Fragment-based Drug Discovery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Fragment-based Drug Discovery Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Fragment-based Drug Discovery Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Fragment-based Drug Discovery Market Share by Country (2016-2027)
Figure 54. Turkey Fragment-based Drug Discovery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Fragment-based Drug Discovery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Fragment-based Drug Discovery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Astex Pharmaceuticals Revenue Growth Rate in Fragment-based Drug Discovery Business (2016-2021)
Figure 58. Alveus Pharmaceuticals Revenue Growth Rate in Fragment-based Drug Discovery Business (2016-2021)
Figure 59. Beactica Revenue Growth Rate in Fragment-based Drug Discovery Business (2016-2021)
Figure 60. Charles River Laboratories Revenue Growth Rate in Fragment-based Drug Discovery Business (2016-2021)
Figure 61. Crown Bioscience Revenue Growth Rate in Fragment-based Drug Discovery Business (2016-2021)
Figure 62. Emerald BioStructures Revenue Growth Rate in Fragment-based Drug Discovery Business (2016-2021)
Figure 63. Evotec Revenue Growth Rate in Fragment-based Drug Discovery Business (2016-2021)
Figure 64. Kinetic Discovery Revenue Growth Rate in Fragment-based Drug Discovery Business (2016-2021)
Figure 65. Proteros Fragments Revenue Growth Rate in Fragment-based Drug Discovery Business (2016-2021)
Figure 66. Sprint Bioscience Revenue Growth Rate in Fragment-based Drug Discovery Business (2016-2021)
Figure 67. Structure Based Design Revenue Growth Rate in Fragment-based Drug Discovery Business (2016-2021)
Figure 68. Sygnature Discovery Revenue Growth Rate in Fragment-based Drug Discovery Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
世界のドラッグデリバリーサービス市場規模・現状・予測（2021年-2027年） In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which new candidate medications are discovered. Historically, drugs were discovered through identifying the active ingredient from traditional remedies or by serendipitousdiscovery. Market Analysis and Insigh…- 世界のアウトソーシング創薬市場規模・現状・予測（2021年-2027年） In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which new candidate medications are discovered. Historically, drugs were discovered through identifying the active ingredient from traditional remedies or by serendipitousdiscovery. Market Analysis and Insigh…
- 世界のドラッグデリバリー技術市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Drug Discovery Technologies Market The global Drug Discovery Technologies market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity…
- 世界のドラッグデリバリー市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Drug Discovery Market The global Drug Discovery market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes a brill…
- 世界のコンピューター支援創薬（CADD）市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Computer-aided Drug Discovery (CADD) Market The global Computer-aided Drug Discovery (CADD) market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and h…